News | June 25, 2009

CAD Detects Cancers on CR Mammography that Go Unnoticed

June 25, 2009 – “Our research confirmed that by adding computer-aided detection, readers are better equipped to detect breast cancers that otherwise would not be identified,” said Rachel F. Brem, M.D., professor of Radiology, and vice chair of Research and Faculty Development at The George Washington University Medical Center, at the Computer Assisted Radiology and Surgery (CARS) 23rd International Congress and Exhibition being held in Berlin, Germany from June 23-27 2009.

The multicenter study evaluated the performance of computer-aided detection (CAD) with computed radiography (CR) for mammography in the detection of breast cancers that had previously been missed, using iCAD’s SecondLook Digital.

Dr. Brem’s findings showed that of the confirmed cancers, 55 percent were missed by at least one of the six readers. CAD correctly pinpointed 88 percent of all cancers, adding further evidence of the clinical need for CAD with CR.

“Even under ideal circumstances, it can be difficult for radiologists to determine what abnormalities in a mammogram could be cancerous and warrant closer evaluation,” said Dr. Brem.

In addition, special sessions on breast CAD including real-time demonstrations, panel discussions and clinical evaluations of iCAD’s technology were shared at CARS.

Original research presented by Dr. Brem further supported the use of computer-aided detection as an effective breast cancer detection tool. Dr. Brem is a member of iCAD Inc.’s board of directors.

For more information: www.icadmed.com

Related Content

Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...
Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite
News | Artificial Intelligence | April 16, 2019
The CE-certified ChestEye artificial intelligence (AI) imaging suite by Oxipit is now available in seven European...
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
Enlitic Closes Series B Funding for Artificial Intelligence Solutions for Radiologists
News | Artificial Intelligence | April 08, 2019
Radiology artificial intelligence (AI) company Enlitic announced the close of its $15 million Series B financing round...
iCAD Highlighting ProFound AI for Tomosynthesis at 2019 SBI Annual Symposium
News | Computer-Aided Detection Software | April 04, 2019
iCAD announced it will present its latest artificial intelligence (AI) software solution for digital breast...
A smart algorithm developed by iCAD

A smart algorithm developed by iCAD outlines and scores a suspicious lesion seen in an image created using digital breast tomography. Displayed is the probability calculated by the algorithm that the outlined area includes a cancerous lesion. Image courtesy of Emily Conant, M.D.

Feature | Artificial Intelligence | April 03, 2019 | Greg Freiherr
  Editor's Note: This article was updated following the SBI symposium.  
Siemens Healthineers Debuts AI-Rad Companion Chest CT
News | Artificial Intelligence | January 25, 2019
Siemens Healthineers presented its first intelligent software assistant for radiology, the AI-Rad Companion Chest CT,...
Telerad Tech Launches MammoAssist AI Software
Technology | Computer-Aided Detection Software | January 25, 2019
Telerad Tech recently announced the launch of MammoAssist, a new artificial intelligence (AI) product to analyze and...
Videos | Artificial Intelligence | December 13, 2018
ITN Editor Dave Fornell and ITN Contributing Editor Greg Freiherr share their insights on the vendors showing...
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...